Search

Alkermes PLC

Closed

SectorHealthcare

45.82 -0.54

Overview

Share price change

24h

Current

Min

45.62

Max

46

Key metrics

By Trading Economics

Income

67M

501K

Sales

103M

496M

P/E

Sector Avg

121.316

56.597

EPS

0.52

Profit margin

0.101

Employees

2,050

EBITDA

76M

54M

Dividends

By Acuity

Next Earnings

27 Oct 2026

Market Stats

By TradingEconomics

Market Cap

-1.1B

7.7B

Previous open

46.36

Previous close

45.82

News Sentiment

By Acuity

50%

50%

126 / 339 Healthcare

Alkermes PLC Chart

Past performance is not a reliable indicator of future results.

Related News

11 Sept 2026, 19:36 UTC

Alkermes shares are lower in Friday's session, lacking specific news. The broader market reacts to the Consumer Price Index release amid interest rate speculation.

10 Sept 2026, 20:13 UTC

Alkermes Plc shares are lower in after-market trading, reflecting bearish sentiment amid the European Central Bank's interest rate hike and inflation concerns.

9 Sept 2026, 20:07 UTC

Alkermes Plc shares are lower today, continuing a recent downward trend amid no specific news. The stock remains below its 20-day moving average.

8 Sept 2026, 21:31 UTC

Alkermes Plc rose in after-market trading, gaining momentum despite broader market pressures and rising crude oil prices. No specific news was identified to explain the move.

4 Sept 2026, 19:36 UTC

Alkermes Plc shares are lower amid broader market pressure from rising Treasury yields and expectations of tighter monetary policy from the Federal Reserve.

3 Sept 2026, 22:01 UTC

Alkermes Plc shares are trading higher in after-market hours, amid a decline in ten-year Treasury yields that may be boosting overall market sentiment.

2 Sept 2026, 21:01 UTC

Alkermes Plc's shares are lower in after-market hours, continuing a downward trend since Wednesday. The stock is near the lower end of its one-month range.

31 Aug 2026, 20:07 UTC

Alkermes shares are lower during Monday's session amid ongoing inflation concerns and expectations for a Federal Reserve interest rate hike.

28 Aug 2026, 22:36 UTC

Alkermes Plc shares are higher in after-market trading, following a notable increase earlier in the session. No specific news was identified to explain the move.

27 Aug 2026, 19:51 UTC

Alkermes Plc shares are lower amid significant downward pressure on biotechnology stocks. Earlier in the session, shares pulled back from a session high.

26 Aug 2026, 19:16 UTC

Alkermes Plc shares are lower today, reaching a session low earlier. No specific news was identified to explain the decline.

21 Aug 2026, 19:51 UTC

Alkermes Plc's shares are higher, supported by strong biotechnology sector momentum, though the stock is pulling back from earlier session highs.

20 Aug 2026, 20:01 UTC

Alkermes Plc shares are lower, impacted by broader weakness in the Biotechnology sector. The stock is trading below its 20-day moving average.

19 Aug 2026, 19:26 UTC

Alkermes Plc is trading higher, maintaining momentum since Tuesday's close, despite no specific news driving the price movement.

18 Aug 2026, 19:16 UTC

News

Alkermes Plc shares are lower after an insider sold 7,576 shares at prices between $49.19 and $49.65, raising investor concerns about the outlook.

17 Aug 2026, 23:31 UTC

Alkermes Plc shares are higher in after-market trading, reflecting a cumulative gain since Monday's close amid broader market volatility and fluctuating crude oil prices.

14 Aug 2026, 19:46 UTC

Alkermes Plc shares are lower today amid broader market weakness following a reported decline in U.S. retail sales for July.

13 Aug 2026, 19:26 UTC

Alkermes Plc shares are lower during Thursday's session, breaking a trend of higher closes. Broader market sentiment may be influenced by rising jobless claims.

12 Aug 2026, 21:51 UTC

Alkermes shares are higher in after-market trading, reflecting positive momentum amid easing inflation concerns and a broader market recovery.

11 Aug 2026, 19:26 UTC

Alkermes Plc shares are trading lower today, remaining near the lower end of their one-month range amid a lack of specific company news.

10 Aug 2026, 19:46 UTC

Alkermes shares are advancing today, despite earlier fluctuations and no specific news. Broader market uncertainty follows a decline in U.S. employment reported last Friday.

6 Aug 2026, 19:36 UTC

Alkermes Plc shares are lower today, reflecting unusual volatility and trading significantly below the 20-day moving average. No specific news was identified.

5 Aug 2026, 19:56 UTC

Alkermes Plc shares are lower Wednesday, continuing a decline since Tuesday's close, despite broader market optimism from falling oil prices and potential diplomatic resolutions.

4 Aug 2026, 19:26 UTC

News

Alkermes Plc shares are lower today amid concerns over recent insider sales by executives, despite the company's gross margin of 80.22%.

3 Aug 2026, 20:02 UTC

Alkermes shares are higher today, driven by significant gains in the overall market and major technology stocks, despite earlier session pullbacks.

31 Jul 2026, 19:36 UTC

Alkermes Plc shares are lower today, impacted by declines in the Biotechnology sub-sector. The stock remains below its 20-day moving average.

30 Jul 2026, 19:58 UTC

Alkermes Plc shares are higher during Thursday's session, reflecting a broader recovery in tech shares despite remaining below the 20-day moving average.

29 Jul 2026, 20:03 UTC

News
Macro Event

Shares declining despite price target increases from JP Morgan, Baird.

28 Jul 2026, 20:02 UTC

News
Event

Alkermes Plc shares are lower after reporting second-quarter earnings of 0 cents per share, below the consensus estimate of 29 cents.

24 Jul 2026, 19:46 UTC

Alkermes Plc shares are lower today, pulling back after an early high. No specific news has been identified to explain the decline.

Peer Comparison

Price change

Alkermes PLC Forecast

Rating Consensus

By TipRanks

Moderate Buy

12 ratings

9

Buy

2

Hold

1

Sell

Sentiment

By Acuity

126 / 339 Healthcare

News Sentiment

Neutral

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Alkermes PLC

Alkermes plc is a biopharmaceutical company. The Company is engaged in the researching, developing and commercializing pharmaceutical products that are designed to address medical needs of patients in therapeutic areas. The Company has a portfolio of marketed drug products and a clinical pipeline of products that address central nervous system (CNS) disorders, such as schizophrenia, depression, addiction and multiple sclerosis (MS). The Company's products include ARISTADA, VIVITROL, INVEGA SUSTENNA, XEPLION, INVEGA TRINZA, TREVICTA, RISPERDAL CONSTA, AMPYRA, FAMPYRA, BYDUREON, Aripiprazole lauroxil, ALKS 5461, ALKS 3831, ALKS 8700, ALKS 6428, ALKS 4230 and ALKS 7119. The Company's product platforms include injectable extended-release microsphere technology, LinkeRx technology, NanoCrystal technology and oral controlled release (OCR) technology. ARISTADA is an extended-release intramuscular injectable suspension for the treatment of schizophrenia.
help-icon Live chat